Who should attend

To attend this masterclass it is required that you are a qualified and practising pharmacist.

The masterclass is ideal for pharmacists with an interest or understanding of paediatric pharmaceutical care. We will accept pharmacists from all specialities and backgrounds and, although the content is primarily designed for overseas pharmacists, UK pharmacists are also more than welcome to attend.

The masterclass is very practical with around a third of the sessions being hands on, so place numbers are limited and early booking is highly recommended to guarantee your place.

Outline programme and format

This masterclass is very hands on and the programme has been put together to demonstrate and share examples of good practice and team work.

Practical elements

Approximatley a third of the masterclass programme is practical and contains the following elements:

Role play – The masterclass includes working in small groups and role playing a series of exercises based on real life hospital situations using actors

Group work – The Paediatric Pharmacy Team will discuss case studies through practical demonstrations on topics such as manipulation, extemporaneous dispensing and risk assessment

Patient interaction – Delegates will have the unique opportunity to review patients at the hospital bed-side on paediatric wards within Evelina Children’s Hospital. This will provide valuable insight into the role of paediatric pharmacists within the hospital setting.

The masterclass programme also contains a series of lectures. Lecture topics include:

•     Practical pharmacology
•     Safe purchasing (unlicensed versus licensed)
•     Paediatric formulations
•     Medication errors and prescription monitoring
•     The role of the pharmacy technician in clinical areas
•     Management of the chronic child
•     Management of the critically ill child

Delegates will also have a tour of the Guy’s and St Thomas’ pharmaceutical manufacturing units.

Course materials

All delegates will be provided with a comprehensive course handbook that they may take away and keep for future reference.

Book your place today >>

Download draft agenda >>

Course faculty

Steve Tomlin

BPharm FRPharmS, FFRPS

Steve is the Consultant Pharmacist – Children’s Services with over 20 years experience in Paediatric Pharmacy practice.

He is an Honorary Clinical Reader at King’s College London University. As Professional Secretary of the Neonatal and Paediatric Pharmacists Group (NPPG) he works closely with the Government and Royal Colleges in the UK. He is lead clinical pharmacist for the London research Network under the National Medicines for Children’s Research Network. Steve is also a pharmacy advisor to Allergy UK Advisory Board and Children’s Hospices UK, lead for medicines on the national Paediatric Health Safety Board and lead Pharmacist for Medicines Information for the Medicines Committee of the Royal College of Paediatrics and Child Health.

Sian Gaze

Highly Specialist Pharmacist, Neonates, Evelina London Children’s Hospital

Sian Gaze is the Lead Neonatal Pharmacist at the Evelina London Children’s Hospital. She graduated from the University of Bath in 2003 and completed her pre-registration pharmacist training at Guy’s and St Thomas’ Hospital. She has been employed by the Trust for over 12 years, starting her career as a resident pharmacist. She joined the paediatric team in 2007 and has worked in every area of the Children’s Hospital. She began specialising in neonatology in 2014.

Sian has an MSc in Advanced Pharmacy Practice from the University of London. She is currently the programme lead for the postgraduate Pharmacy Practice Programme at King’s College London University. As part of this role, Sian helps facilitate the Paediatric Pharmaceutical Care International Internship Programme which is delivered collaboratively by King’s College London, the Evelina London Children’s Hospital and King’s College Hospital.

Nicola Husain

Paediatric Clinical Pharmacist, Evelina London Children’s Hospital

Nicola Husain works as a paediatric clinical pharmacist at the Evelina London Children’s Hospital and her paediatric clinical experience includes intensive care, neonatology, neurology, cardiology, haematology and infectious diseases.  Nicola is also Programme Director for the postgraduate Pharmacy Practice programme at King’s College London, which was recently accredited as a Foundation School by the Royal Pharmaceutical Society.

As part of her role, Nicola helps facilitate the Paediatric Pharmaceutical Care International Internship Programme which is delivered collaboratively by King’s College London, the Evelina London Children’s Hospital and King’s College Hospital.  At undergraduate level, she supports the delivery of clinical and practice-related teaching and facilitates academic links between the MPharm programme at King’s College London and the pharmacy department at Guy’s & St Thomas’ NHS Foundation Trust.

Nicola has experience of delivering training, support and mentorship to healthcare professionals involved in the care of children with HIV in South Africa through her work with the charity CHIVA Africa.  She has also undertaken extended trips to India where she has worked in government hospitals and for the Indian NGO Latika Roy, where her work focussed on improving the safe and effective use of medicines for children with complex disabilities.

Book your place today >>

Download draft agenda >>

Masterclass fee: £850

The course fee covers all course materials and tuition but excludes accommodation and travel expenses.

Book your place today >>

Download draft agenda >>

Enquiries

If you have any queries about the masterclass or registering then please email events@gstt.nhs.uk

We also offer…

Did you know that we also offer Visiting Professional Programmes for paediatric pharmaceutical care. To find out details simply click here

Evelina London Children’s Hospital

The final day of the masterclass revolves around patient case reviews at the hospital bedside. This is conducted in Evelina London Children’s Hospital, which is part of Guy’s and St Thomas’ NHS Foundation Trust and the second largest provider of children’s services in London.

The hospital includes:

• 151 inpatient beds, including 20 intensive care beds
• 46-cot neonatal unit
• 5 operating theatres, plus 1 cardiac theatre in East Wing, St Thomas’
• a full children’s imaging service with MRI scanner, x-ray and ultrasound
• a kidney dialysis unit
• an outpatients department and a medical day care unit
• a hospital school.

The hospital is unique in its design and has been made to be a hospital that does not feel like a hospital.

Hospital accommodation

The hospital provides accommodation near the hospital for staff and visitors. Rooms can be booked on a nightly basis at a charge of £60 per night for a single room and £70 per night for a twin room. En-suite rooms are priced at £90 (limited availability).

At Gassiot House Lodge (for St Thomas’ Hospital), contact Gassiot House Accommodation Office:

• Phone:  +44 (0)20 7188 0276
• Email: stthomas.accommodation@gstt.nhs.uk

At Counting House Lodge (for Guy’s Hospital), contact West Wing Accommodation Office:

• Phone:  +44 (0)20 7188 0474
• Email: guys.accommodation@gstt.nhs.uk

Rosemont Pharmaceuticals Limited is dedicated to improving the health and wellbeing of people through the development, manufacturing and marketing of high quality generic oral liquid medicines. We are leading specialists in the supply of liquid medicines for people who have swallowing difficulties, or for those who need a precise measured dose unavailable in a solid tablet or capsule.

Our facilities are inspected by both the UK and US regulatory authorities and through adherence to Good Manufacturing Practice (GMP) and international quality control standards; we ensure that all our medicines can be used with a high degree of confidence. Through significant research and development, we manufacture a range of more than 160 different liquid formulations covering 11 BNF categories. Acquired by Perrigo Company plc in 2013, we have 49 years’ experience in supplying oral liquid medicines to customers who see Rosemont as ‘The Source of Liquid Solutions’.

Rosemont’s commitment is to the promotion of best practice when administering medication; through continuing support of healthcare professionals and provision of free educational training meetings and materials to assist them in delivering the best possible care for their patients.

Proveca is a UK based pharmaceutical company specialising in the development and licensing of off-patent medicines for children throughout Europe www.proveca.co.uk. Around 20% of the EU population (100m) is under 18 years of age, yet the majority of medicines used in children have not been formulated for, or evaluated in children.  Marketing approval (product licence) is gained via a Paediatric Use Marketing Authorisation (PUMA), a regulatory route developed specifically for licensing off-patent medicines for children in Europe.

Proveca was founded by Dr Helen Shaw, a physician with over 25 years’ experience in the pharmaceutical industry and Dr Simon Bryson, a pharmaceutical professional whose PhD is in Paediatric Medication Adherence. Proveca’s first PUMA (Sialanar, paediatric licensed oral glycopyrronium bromide) was granted in September 2016 and its pipeline contains medicines for heart failure and epilepsy.

For more information contact:

Robert Holmes

Email: robertholmes@proveca.co.uk

Tel: 07931 684124

Fresenius Kabi is the leader in infusion therapy and clinical nutrition in Europe.  It is focused on the therapy and care of critically and chronically ill patients in both the hospital and home environment.  The company develops, manufactures and markets products that offer efficient clinical outcomes combined with a commitment to quality and patient safety.

With a corporate philosophy of “Caring for Life” the company’s goal is to improve the patient’s quality of life.  This means that we continuously strive to develop our specialist skills in the fields of nutrition, infusion therapy, oncology and homecare. In doing so we provide innovative solutions to meet the highest standards of patient care.

The company offers a wide range of products and services including;

• Infusion Therapy Solutions
• IV Drugs
• Enteral and Parenteral Nutrition
• Specials Service offering ready to use IV drugs, infusion solutions and parenteral nutrition presentations
• Medical Devices, and Technical Services
• Homecare Service via Calea UK Ltd, part of the Fresenius Kabi Group.

For more information contact:

Karen Rosevear

Email:  karen.rosevear@fresenius-kabi.com

Tel: +44 (0)1928 533732

Supported by the European Association of Hospital Pharmacists (EAHP)

see also

23rd Congress of the EAHP – 21 – 23 March 2018 in Gothenburg, Sweden

EAHP is pleased to invite you to the 23rd Congress of the EAHP 21st- 23rd March 2018 with the theme of “Hospital pharmacists – Show us what you can do!”. The scientific program is well advanced and is relevant for you as a hospital pharmacist dealing with the challenges of economic restrictions and increased demands. This congress provides an opportunity to demonstrate what hospital pharmacists have achieved, to provide inspiration for future development and to energise us for the road ahead. This opportunity to showcase the benefits facilitated by hospital pharmacists will influence decision makers, multidisciplinary team members and patients to demand hospital pharmacists’ full engagement in the medication process.

EAHP’s annual congress is the largest congress for hospital pharmacy in Europe and is attended by pharmacists from all over the world. This Congress continues to provide you with an exceptional opportunity to meet, network and share expertise and best practice with colleagues while keeping up to date with the latest developments in hospital pharmacy.

Important dates:
–          15 October 2017: Deadline for abstract and “Good Practice Initiative” submission
–          Before 1 December 2017: Registration – early rate
–          BEGINNING 1 December 2017: Registration- 2nd rate
–          BEGINNING 1 February 2018: Registration – 3rd rate and on-site